Capital Fund Management (CFM)
VYGR icon

Capital Fund Management (CFM)’s Voyager Therapeutics VYGR Stock Holding History

Capital Fund Management (CFM)’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-17,521
Closed -$221K – 1411
2020
Q2 		$221K Sell
17,521
-41,436
-70% -$482K ﹤0.01% 964
2020
Q1 		$539K Sell
58,957
-17,553
-23% -$201K 0.01% 1010
2019
Q4 		$1.07M Buy
+76,510
New +$1.11M 0.01% 1058

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Fund Management (CFM)'s VYGR Position: Q3 2020 in Review

Capital Fund Management (CFM) sold out of Voyager Therapeutics (VYGR) in Q3 2020, closing a stake of 17,521 shares — an estimated $221K sold.

Capital Fund Management (CFM) first reported a position in VYGR in Q4 2019 and held it in 3 quarters. The position peaked at $1.07M in Q4 2019. 110 funds tracked by Wall St. Rank hold VYGR as of Q3 2020.

  • Capital Fund Management (CFM) reported no remaining Voyager Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 17,521 Voyager Therapeutics shares in Q3 2020, an estimated $221K.
  • Capital Fund Management (CFM) first reported a position in Voyager Therapeutics in Q4 2019 and held it in 3 quarters.
  • Capital Fund Management (CFM)'s Voyager Therapeutics position peaked at $1.07M in Q4 2019.
  • 110 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2020.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2020, filed 13 Nov 2020.